Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Free Cash Flow Growth TrendStable
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P43
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
3 yr
Consecutive declineStable
PeriodValue
2025-2.56%
2024-2.35%
20231.64%
202231.08%
2021-52.70%
2020-54.03%
2019-478.55%
20180.00%